JPS5938227B2 - 2-substituted-1,3-diazacycloalkane compounds - Google Patents
2-substituted-1,3-diazacycloalkane compoundsInfo
- Publication number
- JPS5938227B2 JPS5938227B2 JP20276A JP20276A JPS5938227B2 JP S5938227 B2 JPS5938227 B2 JP S5938227B2 JP 20276 A JP20276 A JP 20276A JP 20276 A JP20276 A JP 20276A JP S5938227 B2 JPS5938227 B2 JP S5938227B2
- Authority
- JP
- Japan
- Prior art keywords
- benzhydryl
- melting point
- hydrogen
- lower alkyl
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 title claims description 17
- -1 1-methyl-2-benzhydryl iminoimidazolidine Chemical compound 0.000 claims description 32
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 13
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical class 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 239000003472 antidiabetic agent Substances 0.000 claims description 4
- 229940126904 hypoglycaemic agent Drugs 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 75
- 238000002844 melting Methods 0.000 description 36
- 230000008018 melting Effects 0.000 description 36
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- IHPGDBCQUSRFER-UHFFFAOYSA-N [amino(methylsulfanyl)methylidene]-benzhydrylazanium;iodide Chemical compound I.C=1C=CC=CC=1C(N=C(N)SC)C1=CC=CC=C1 IHPGDBCQUSRFER-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- UZQOTGNKCVYIFU-UHFFFAOYSA-N n-benzhydryl-4,5-dihydro-1h-imidazol-2-amine Chemical compound N1CCNC1=NC(C=1C=CC=CC=1)C1=CC=CC=C1 UZQOTGNKCVYIFU-UHFFFAOYSA-N 0.000 description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 7
- 125000001797 benzyl group Chemical class [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- 239000012312 sodium hydride Substances 0.000 description 7
- 229910000104 sodium hydride Inorganic materials 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 6
- REKQCRSUOJRCDV-UHFFFAOYSA-N [isocyano(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C([N+]#[C-])C1=CC=CC=C1 REKQCRSUOJRCDV-UHFFFAOYSA-N 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 4
- KFIGICHILYTCJF-UHFFFAOYSA-N n'-methylethane-1,2-diamine Chemical compound CNCCN KFIGICHILYTCJF-UHFFFAOYSA-N 0.000 description 4
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- RIWNFZUWWRVGEU-UHFFFAOYSA-N isocyanomethylbenzene Chemical compound [C-]#[N+]CC1=CC=CC=C1 RIWNFZUWWRVGEU-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000005700 Putrescine Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- HYKUTRCFLVWMTA-UHFFFAOYSA-N n-[(4-chlorophenyl)-phenylmethyl]-4,5-dihydro-1h-imidazol-2-amine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)N=C1NCCN1 HYKUTRCFLVWMTA-UHFFFAOYSA-N 0.000 description 2
- NNYZYZUKDRLUFW-UHFFFAOYSA-N n-benzhydryl-1-methyl-5,6-dihydro-4h-pyrimidin-2-amine;hydrochloride Chemical compound Cl.CN1CCCN=C1NC(C=1C=CC=CC=1)C1=CC=CC=C1 NNYZYZUKDRLUFW-UHFFFAOYSA-N 0.000 description 2
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XAFODXGEQUOEKN-UHFFFAOYSA-N (4-chlorophenyl)-phenylmethanamine Chemical compound C=1C=C(Cl)C=CC=1C(N)C1=CC=CC=C1 XAFODXGEQUOEKN-UHFFFAOYSA-N 0.000 description 1
- PDKFYJNVRGUNSS-UHFFFAOYSA-N 1-methylsulfanyl-4,5-dihydroimidazole;hydroiodide Chemical compound I.CSN1CCN=C1 PDKFYJNVRGUNSS-UHFFFAOYSA-N 0.000 description 1
- CRVBQABBEKLFIN-UHFFFAOYSA-N 1-phenylethane-1,2-diamine Chemical compound NCC(N)C1=CC=CC=C1 CRVBQABBEKLFIN-UHFFFAOYSA-N 0.000 description 1
- BFYRXCWLDJORHM-UHFFFAOYSA-N 2-chloro-4,5-dihydro-1h-imidazole Chemical compound ClC1=NCCN1 BFYRXCWLDJORHM-UHFFFAOYSA-N 0.000 description 1
- KDRUIMNNZBMLJR-UHFFFAOYSA-N 2-isopropylaminoethylamine Chemical compound CC(C)NCCN KDRUIMNNZBMLJR-UHFFFAOYSA-N 0.000 description 1
- PZZRSEUDGCFXIH-UHFFFAOYSA-N 2-methylsulfanyl-4,5-dihydro-1h-imidazol-1-ium;iodide Chemical compound I.CSC1=NCCN1 PZZRSEUDGCFXIH-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LCGISIDBXHGCDW-VKHMYHEASA-N L-glutamine amide Chemical compound NC(=O)[C@@H](N)CCC(N)=O LCGISIDBXHGCDW-VKHMYHEASA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 102220523035 Transmembrane protein 44_H24N_mutation Human genes 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005526 alkyl sulfate group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- BWKQVWQYYSAKHC-UHFFFAOYSA-N methylthiourea;hydroiodide Chemical compound I.CNC(N)=S BWKQVWQYYSAKHC-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- ACYBVNYNIZTUIL-UHFFFAOYSA-N n'-benzylethane-1,2-diamine Chemical compound NCCNCC1=CC=CC=C1 ACYBVNYNIZTUIL-UHFFFAOYSA-N 0.000 description 1
- DFPGBRPWDZFIPP-UHFFFAOYSA-N n'-butylethane-1,2-diamine Chemical compound CCCCNCCN DFPGBRPWDZFIPP-UHFFFAOYSA-N 0.000 description 1
- SCZVXVGZMZRGRU-UHFFFAOYSA-N n'-ethylethane-1,2-diamine Chemical compound CCNCCN SCZVXVGZMZRGRU-UHFFFAOYSA-N 0.000 description 1
- QHJABUZHRJTCAR-UHFFFAOYSA-N n'-methylpropane-1,3-diamine Chemical compound CNCCCN QHJABUZHRJTCAR-UHFFFAOYSA-N 0.000 description 1
- VIWQPXMEXLXLBX-UHFFFAOYSA-N n-benzhydryl-1,4,5,6-tetrahydropyrimidin-2-amine Chemical compound N1CCCNC1=NC(C=1C=CC=CC=1)C1=CC=CC=C1 VIWQPXMEXLXLBX-UHFFFAOYSA-N 0.000 description 1
- NPTJJYRGHGSFAG-UHFFFAOYSA-N n-benzhydryl-1-methyl-4,5-dihydroimidazol-2-amine;hydroiodide Chemical compound I.CN1CCN=C1NC(C=1C=CC=CC=1)C1=CC=CC=C1 NPTJJYRGHGSFAG-UHFFFAOYSA-N 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は強力な血糖降下作用を有する2一置換−1,3
−ジアザシクロアルカン類化合物及びこの化合物を有効
成分とする血糖降下剤に関するものであり、この化合物
は次の一般式(1)で表わされる。DETAILED DESCRIPTION OF THE INVENTION The present invention provides 2-substituted -1,3
This invention relates to a -diazacycloalkane compound and a hypoglycemic agent containing this compound as an active ingredient, and this compound is represented by the following general formula (1).
▲VO4V啼
式中R1は水素、ハロゲン又はアルキルを、R2はシク
ロアルキル、ピリジル又はハロゲン、アルキル若しくは
アルコキシが置換することあるフエニルを、R3は水素
、アルキル、ヒドロキシアルキル又はアラルキルを、R
4は水素、アルキル又はフエニルを、nは1〜3を意味
する。▲VO4V In the formula, R1 is hydrogen, halogen or alkyl, R2 is cycloalkyl, pyridyl or phenyl which may be substituted with halogen, alkyl or alkoxy, R3 is hydrogen, alkyl, hydroxyalkyl or aralkyl, R
4 means hydrogen, alkyl or phenyl, and n means 1-3.
この化合物は2−ベンヅヒドリルイミノ一1,3−ジア
ザシクロアルカン又は2−(α−R2置換ベンジル)イ
ミノ−1,3−ジアザシクロアルカン類と呼ばれるが、
その互変異性体である式(…)の2−ベンヅヒドリルア
ミノ一1,3−ジアザシクロアルケン又は2−(α−R
2置換ベンジル)アミノ−1,3−ジアザシクロアルケ
ン類としても表わされる。This compound is called 2-benzuhydrylimino-1,3-diazacycloalkane or 2-(α-R2-substituted benzyl)imino-1,3-diazacycloalkane.
Its tautomer, 2-benzhydrylamino-1,3-diazacycloalkene or 2-(α-R
Also represented as (2-substituted benzyl)amino-1,3-diazacycloalkenes.
本明細書中では、便宜的に(1)式に統一して表示し、
呼称する。In this specification, for convenience, it is expressed as formula (1),
To call.
本発明の2一置換−1,3−ジアザシクロアルカン類化
合物又はその塩は強力な血糖降下作用を有し、経口糖尿
病用剤として有用である。The 2-monosubstituted-1,3-diazacycloalkane compound or salt thereof of the present invention has a strong hypoglycemic effect and is useful as an oral antidiabetic agent.
この血糖低下作用を、空腹ラツトに経口で25〜/Kg
又は腹腔内10即/K9投与して測定した結果で示すと
次表の如くである。本発明の化合物を製造するには種々
の方法があるが、その例を示せば次の如くである。This blood sugar lowering effect can be achieved by oral administration of 25~/kg to hungry rats.
Or, the following table shows the results measured by intraperitoneal administration of 10 K9 immediately. There are various methods for producing the compound of the present invention, examples of which are as follows.
但し式中Xはハロゲンを、Yはアミンと置換可能な基、
例えばハロゲン、アルキルメルカプト、ニトロアミノ等
を示し、Zはアルキル化に際し活性な基、例えばハロゲ
ン、アルキル硫酸根等を意味し、Rは水素又はアルキル
を示し、Qはベンズヒドリル基、α一置換ベンジル基等
を示す。また、R3,R4及びnは前出と同じものを意
味する。/
a)式Q−N=C3で表わされるイソシアニド・ハロゲ
ニドを式NH−CH−(CH2)11−NH2で表わさ
れるジチ3ミン漏Σ反応させる。However, in the formula, X is a halogen, Y is a group that can be substituted with an amine,
For example, it represents halogen, alkylmercapto, nitroamino, etc., Z means a group active in alkylation, such as halogen, alkyl sulfate group, etc., R represents hydrogen or alkyl, and Q represents benzhydryl group, α-monosubstituted benzyl group, etc. etc. Further, R3, R4 and n have the same meanings as above. /a) An isocyanide halide represented by the formula Q-N=C3 is subjected to a dithimine leakage Σ reaction represented by the formula NH-CH-(CH2)11-NH2.
b)式Q−NH−C=NH−X−で表わされるイ0 [
Vソチウロニウム・ハロゲニドをa)と同じジアミン類
と反応させる。b) I0 [
V Sotiuronium halide is reacted with the same diamines as in a).
c)式Q−NH2のアミン類と式Y(.−ゞ11.二2
)1で表わされる化合物と反応させる。c) Amines of formula Q-NH2 and formula Y (.-ゞ11.22
) React with the compound represented by 1.
d)
式Q−N:<1゛
\ し112ノn
の化合物に式
a)又はb)の反応は、適当な溶媒中又は溶媒なしにO
〜200℃の温度で行うのが適当であり溶媒としてはエ
ーテル類、アルコール類等が好ましい。d) The reaction of formula a) or b) on a compound of formula Q-N:
It is appropriate to carry out the reaction at a temperature of ~200°C, and ethers, alcohols, etc. are preferable as the solvent.
c)の反応は溶媒中又は溶媒なしに室温乃至加熱して行
い、反応速度を増すために外部加熱することが望ましい
。d)の反応は適当な溶媒中室温乃至加熱下に行うのが
適当であり、一般にアルキル化に際し用いられる脱酸試
薬、例えば水素化アルカリ、アルカリアルコラード等を
用いるのが好ましい。この反応において、アルキル化さ
れる位置はb)の反応の目的物と一致することから確認
された。以上の如き方法で製造される化合物はそれらの
生理学的に許容しうる酸付加塩に変換しうる。The reaction c) is carried out in a solvent or without a solvent at room temperature or under heating, preferably external heating to increase the reaction rate. The reaction d) is suitably carried out in a suitable solvent at room temperature or under heating, and it is preferable to use a deoxidizing reagent generally used in alkylation, such as an alkali hydride or an alkali alcoholade. In this reaction, the position to be alkylated was confirmed because it coincided with the target product of the reaction in b). Compounds produced by the methods described above can be converted into their physiologically acceptable acid addition salts.
塩形成に適した酸類は、例えば塩酸、臭化水素酸、ヨウ
化水素酸、硫酸、リン酸、硝酸のような無機酸類または
酢酸、プロピオン酸、シユウ酸、マロン酸、マレイン酸
、フマール酸、乳酸、酒石酸、安息香酸、サルチル酸、
メタンスルホン酸等の有機酸類である。本発明の化合物
は血糖降下作用、血小板凝集阻止作用等の薬理学的活性
を有し医薬として有用である。Acids suitable for salt formation are, for example, inorganic acids such as hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, phosphoric acid, nitric acid or acetic acid, propionic acid, oxalic acid, malonic acid, maleic acid, fumaric acid, lactic acid, tartaric acid, benzoic acid, salicylic acid,
Organic acids such as methanesulfonic acid. The compound of the present invention has pharmacological activities such as hypoglycemic action and platelet aggregation inhibiting action, and is useful as a medicine.
また急性毒性は、1−メチル−2−ベンズヒドリルイミ
ノイミダゾリジン塩酸塩でラツト経口LD5O884.
3η/Kg、マウス経口276.3〜/Kgであつた。
本発明の化合物を血糖降下剤として用いるには、適当な
賦形剤、崩壊剤、潤滑剤、結合剤等を適宜用い経口投与
用の錠剤、カプセル剤、散剤等にすることができる。In addition, acute toxicity was observed in rats with 1-methyl-2-benzhydryl iminoimidazolidine hydrochloride.
3η/Kg, and 276.3~/Kg for mice orally.
To use the compound of the present invention as a hypoglycemic agent, it can be made into tablets, capsules, powders, etc. for oral administration using appropriate excipients, disintegrants, lubricants, binders, etc.
その他洛液、シロツプ、注射剤等も目的に応じ適宜製造
することができる。人間に対する投与量としては通常は
100〜750〜/日で充分である。以下製造例を挙げ
て説明する。Other liquids, syrups, injections, etc. can also be produced as appropriate depending on the purpose. A dosage of 100 to 750 doses per day is usually sufficient for humans. A manufacturing example will be described below.
実施例 1
ベンズヒドリルアミン7.3f7と2−メチルメルカブ
ト一2−イミダゾリン・ヨウ化水素酸塩4.889をメ
タノール10m1に混和し、3時間加熱還流する。Example 1 7.3f7 of benzhydrylamine and 4.8899 of 2-methylmercabuto-2-imidazoline hydroiodide are mixed in 10 ml of methanol and heated under reflux for 3 hours.
冷後メタノールを留去し、残渣は10%水酸化ナトリウ
ムでアルカリ性としたのち、クロロホルム200m1で
可溶分を抽出し水洗乾燥する。クロロホルムを減圧除去
後、さらに減圧下に未反応のベンズヒドリルアミンを除
去し、残渣を少量のアセトンと処理すると2−ベンズヒ
ドリルイミノーイミダゾリジンが結晶状に得られた。融
点189〜191ジC0実施例 2
ベンズヒドリルアミン229と2−ニトロアミノ−2−
イミダゾリン5.29を混和し、180〜200℃に3
0分加熱反応する。After cooling, methanol is distilled off, and the residue is made alkaline with 10% sodium hydroxide, and then the soluble content is extracted with 200 ml of chloroform, washed with water, and dried. After removing chloroform under reduced pressure, unreacted benzhydrylamine was further removed under reduced pressure, and the residue was treated with a small amount of acetone to obtain 2-benzhydryl imino imidazolidine in crystal form. Melting point 189-191 diC0 Example 2 Benzhydrylamine 229 and 2-nitroamino-2-
Mix 5.29 of imidazoline and heat to 180-200℃ for 3
Heat and react for 0 minutes.
冷後、未反応のベンズヒドリルアミンを減圧下に除去後
、実施例1と同様にして2−ベンズヒドリルイミノーイ
ミダゾリジンが得られる。実施例 3
ベンズヒドリルアミン2.26gを2−クロル−2−イ
ミダゾリン2.59を含むエーテル溶液30dと2日間
室温で放置する。After cooling, unreacted benzhydrylamine is removed under reduced pressure, and 2-benzhydryliminoimidazolidine is obtained in the same manner as in Example 1. Example 3 2.26 g of benzhydrylamine are left at room temperature for 2 days with 30 d of an ether solution containing 2.59 g of 2-chloro-2-imidazoline.
以下実施例1と同様にして2−ベンズヒドリルイミノー
イミダゾリジンが得られた。このものをメタノールに溶
解し、濃塩酸を等モル加え、減圧乾固するとその塩酸塩
がえられた。融点207〜209℃o実施例 4
ベンズヒドリルアミン1.89(!:1−メチル−2−
メチルメルカプト−2−イミダゾリン・ヨウ化水素酸塩
3.4f1をクロロホルム30m1にとか17−室温に
2日間放置する。Thereafter, 2-benzhydryliminoimidazolidine was obtained in the same manner as in Example 1. This product was dissolved in methanol, an equimolar amount of concentrated hydrochloric acid was added, and the solution was dried under reduced pressure to obtain its hydrochloride. Melting point 207-209°C o Example 4 Benzhydrylamine 1.89 (!: 1-methyl-2-
3.4 fl of methylmercapto-2-imidazoline hydroiodide is dissolved in 30 ml of chloroform and left at room temperature for 2 days.
クロロホルムを留去すると1−メチル−2−ベンズヒド
リルイミノーイミダゾリジン・ヨウ化水素酸塩が得られ
る。融点254〜256℃。実施例 5
α−(p−クロルフエニル)ベンジルアミン3.379
と2−メチルメルカプト−2−イミダゾリン・ヨウ化水
素酸塩4.549を混和し、150〜160℃に20分
加熱する。When chloroform is distilled off, 1-methyl-2-benzhydryliminoimidazolidine hydroiodide is obtained. Melting point: 254-256°C. Example 5 α-(p-chlorophenyl)benzylamine 3.379
and 4.549 g of 2-methylmercapto-2-imidazoline hydroiodide and heated to 150 to 160°C for 20 minutes.
冷後メタノールに溶解し、水酸化ナトリウムで遊離塩基
として2一(α−(p−クロロフエニル)ベンジル)イ
ミノ−イミダゾリンを得た。融点187〜189たC0
実施例 6
N−ベンズヒドリル一S−メチルイソチウロニウムイオ
ダイド5.649とエチレンジアミン8.539をメタ
ノール40m1に加え15時間加熱還流する。After cooling, it was dissolved in methanol and added as a free base with sodium hydroxide to obtain 2-(α-(p-chlorophenyl)benzyl)imino-imidazoline. Melting point: 187-189 C0 Example 6 5.649 g of N-benzhydryl-S-methylisothiuronium iodide and 8.539 g of ethylenediamine were added to 40 ml of methanol and heated under reflux for 15 hours.
冷後メタノール及び過剰のエチレンジアミンを減圧下に
除去し、残渣にエタノール30m1を加えて溶解し、水
酸化ナトリウムでアルカリ性とし、クロロホルムで抽出
し、水洗、乾燥する。クロロホルムを留去すると残渣は
結晶する。イソプロピルアルコールから再結晶し融点1
89〜190℃の2−ベンズヒドリルイミノーイミダゾ
リジン2.709が得られた。実施例 7
N−ベンズヒドリル一S−メチルイソチウロニウムイオ
ダイド3.849と1,3−プロパンジアミン7.59
をメタノール25m1に加え16時間加熱還流する。After cooling, methanol and excess ethylenediamine are removed under reduced pressure, and the residue is dissolved in 30 ml of ethanol, made alkaline with sodium hydroxide, extracted with chloroform, washed with water, and dried. When the chloroform is distilled off, the residue crystallizes. Recrystallized from isopropyl alcohol, melting point 1
2.709 of 2-benzhydryl iminoimidazolidine was obtained at 89-190°C. Example 7 N-benzhydryl-S-methylisothiuronium iodide 3.849 and 1,3-propanediamine 7.59
was added to 25 ml of methanol and heated under reflux for 16 hours.
以下実施例6と同様に処理し遊離塩基を得たのち、これ
をメタノール中塩酸を加えると2−ベンズヒドリルイミ
ノ一1,3−ジアザシクロヘキサン塩酸塩を得た。融点
238〜2420C0N−ベンズヒドリル一S−メチル
イソチウロニウムイオダイド5,09と1,4−ジアミ
ノブタン1.39を混和し、185〜190℃に15分
加熱する。Thereafter, the same procedure as in Example 6 was carried out to obtain a free base, which was then added with hydrochloric acid in methanol to obtain 2-benzhydrylimino-1,3-diazacyclohexane hydrochloride. Melting point 238-2420C0N-benzhydryl-S-methylisothiuronium iodide 5,099 and 1,4-diaminobutane 1.39 are mixed and heated to 185-190°C for 15 minutes.
以下実施例7と同様にして遊離塩基としたのち、融点2
27〜229.5℃の2−ベンズヒドリルイミノ一1,
3−ジアザシクロヘプタン塩酸塩とした。実施例 9
N−α−(0−クロルフエニル)ベンジル一S−メチル
イソチウロニウムイオダイド0.429とエチレンジア
ミン0.609をメタノール中15時間加熱反応し、以
下実施例7と同様にして2一(α−(0−クロルフエニ
ル)ベンジル)イミノ−イミダゾリジン塩酸塩を得た。After preparing the free base in the same manner as in Example 7,
2-benzhydryl imino-1 at 27-229.5°C,
3-diazacycloheptane hydrochloride. Example 9 0.429 of N-α-(0-chlorophenyl)benzyl-S-methylisothiuronium iodide and 0.609 of ethylenediamine were heated and reacted in methanol for 15 hours. α-(0-chlorophenyl)benzyl)imino-imidazolidine hydrochloride was obtained.
融点205〜207ダC0実施例 10
N−α−(p−クロルフエニル)ベンジル一Sーメチル
イソチウロニウムイオダイド0.849とエチレンジア
ミン1.209をメタノール中15時間加熱反応し、以
下実施例7と同様にして2一(α−(p−クロルフエニ
ル)ベンジル)イミノイミダゾリジンを得た。Melting point 205-207 da C0 Example 10 N-α-(p-chlorophenyl)benzyl-S-methylisothiuronium iodide 0.849 and ethylenediamine 1.209 were reacted by heating in methanol for 15 hours. Similarly, 2-(α-(p-chlorophenyl)benzyl)iminoimidazolidine was obtained.
融点187〜189℃o実施例 11N−ベンズヒドリ
ル一S−メチルイソチウロニウムイオダイド3.849
とN−メチルエチレンジアミン7.49をメタノール中
15時間加熱反応し、以下実施例7と同様にして1−メ
チル−2−ベンズヒドリルイミノーイミダゾリジン塩酸
塩を得た。Melting point 187-189°C oExample 11N-benzhydryl-S-methylisothiuronium iodide 3.849
and 7.49 g of N-methylethylenediamine were heated and reacted in methanol for 15 hours, and the same procedure as in Example 7 was carried out to obtain 1-methyl-2-benzhydryl imino imidazolidine hydrochloride.
融点254〜256℃。実施例 12
N−ベンズヒドリル一S−メチルイツチウロニウムイオ
ダイド3.8411::.N−エチルエチレンジアミン
2.659をメタノール中16時間加熱反応させ、以下
実施例7と同様にして1−エチル−2−ベンズヒドリル
イミノーイミダゾリジン塩酸塩を得た。Melting point: 254-256°C. Example 12 N-benzhydryl-S-methylitiuronium iodide 3.8411::. 2.659 g of N-ethylethylenediamine was heated and reacted in methanol for 16 hours, and the same procedure as in Example 7 was carried out to obtain 1-ethyl-2-benzhydryl imino imidazolidine hydrochloride.
融点274〜276ミC0実施例 13
N−ベンズヒドリル一S−メチルイソチウロニウムイオ
ダイド3,849とN−n−ブチルエチレンジアミン7
.59をメタノール中13時間加熱反応させ、以下実施
例7と同様にして1−n−ブチル−2−ベンズヒドリル
イミノーイミダゾリジン塩酸塩を得る。Melting point 274-276mm C0 Example 13 N-benzhydryl-S-methylisothiuronium iodide 3,849 and N-n-butylethylenediamine 7
.. 59 was heated and reacted in methanol for 13 hours, and the same procedure as in Example 7 was carried out to obtain 1-n-butyl-2-benzhydryl imino imidazolidine hydrochloride.
融点240〜242℃o実施例 14
N−ベンズヒドリル一S−メチルーイソチウロニウムイ
オダイド3.849とN−ベンジルエチレンジアミン1
59をメタノール中16時間加熱反応させ、以下実施例
7と同様にして1−ベンジル一2−ベンズヒドリルイミ
ノーイミダゾリジン塩酸塩を得た。Melting point 240-242°C o Example 14 N-benzhydryl-S-methyl-isothiuronium iodide 3.849 and N-benzylethylenediamine 1
59 was heated and reacted in methanol for 16 hours, and the same procedure as in Example 7 was carried out to obtain 1-benzyl-2-benzhydryl iminoimidazolidine hydrochloride.
融点237〜239℃。実施例 15
N−ベンズヒドリル一S−メチルイソチウロニウムイオ
ダイド7.689をN−メチル−1,3−ジアミノプロ
パン17.69をエタノール中20時間加熱反応させ、
以下実施例7と同様にして1ーメチル−2−ベンズヒド
リルイミノ一1,3−ジアザシクロヘキサン塩酸塩を得
た。Melting point 237-239°C. Example 15 7.689 of N-benzhydryl-S-methylisothiuronium iodide was heated to react with 17.69 of N-methyl-1,3-diaminopropane in ethanol for 20 hours.
Thereafter, in the same manner as in Example 7, 1-methyl-2-benzhydrylimino-1,3-diazacyclohexane hydrochloride was obtained.
融点219〜221クC0実施例 16
N−ベンズヒドリル一S−メチルイソチウロニウムイオ
ダイド3.849と1,2−ジアミノプロパン7.49
をメタノール中16時間加熱反応させ、以下実施例7と
同様にして4−メチル−2−ベンズヒドリルイミノーイ
ミダゾリジン塩酸塩を得る。Melting point 219-221 C0 Example 16 N-benzhydryl-S-methylisothiuronium iodide 3.849 and 1,2-diaminopropane 7.49
The mixture was heated and reacted in methanol for 16 hours, and the same procedure as in Example 7 was carried out to obtain 4-methyl-2-benzhydryl imino imidazolidine hydrochloride.
融点225〜227イC実施例 17
N−ベンズヒドリル一S−メチルイソチウロニウムイオ
ダイド1.09と2−フエニルエチレンジアミン2.1
39をメタノール中]5時間加熱反応させ、以下実施例
7と同様にして4−フエニル一2−ベンズヒドリルイミ
ノーイミダゾリジン塩酸塩を得る。Melting point: 225-227C Example 17 N-benzhydryl-S-methylisothiuronium iodide 1.09 and 2-phenylethylenediamine 2.1
39 in methanol] for 5 hours, and then in the same manner as in Example 7, 4-phenyl-2-benzhydryliminoimidazolidine hydrochloride was obtained.
融点155〜157℃。実施例 18
2−ベンズヒドリルイミノーイミダゾリジン1.259
と水素化ナトリウム0.169を乾燥ジメチルホルムア
ミド7mlに加え20分攪拌する。Melting point: 155-157°C. Example 18 2-Benzhydryl iminoimidazolidine 1.259
and 0.169 ml of sodium hydride were added to 7 ml of dry dimethylformamide and stirred for 20 minutes.
ここへヨードメチル1.009を加え室温で1〜2時間
攪拌する。反応後ジメチルホルムアミドを減圧除去し、
水を加えたのちクロロホルムで可溶分を抽出し、水洗、
乾燥後クロロホルムは留去する。残渣はメタノール少量
に溶解し、塩酸を加えて塩酸塩としてメタノールを留去
し、1−メチル−2ーベンズヒドリルイミノーイミダゾ
リジン塩酸塩を得た。融点254〜256℃。実施例
19
2−ベンズヒドリルイミノーイミダゾリジン1.259
と水素化ナトリウム0.169およびヨウ化エチル1.
109を用い、反応させ以下実施例18と同様に行い、
1−エチル−2−ベンズヒドリルイミノーイミダゾリジ
ン塩酸塩を得た。Add 1.009 g of iodomethyl to this and stir at room temperature for 1 to 2 hours. After the reaction, dimethylformamide was removed under reduced pressure.
After adding water, extract the soluble content with chloroform, wash with water,
After drying, chloroform is distilled off. The residue was dissolved in a small amount of methanol, and hydrochloric acid was added to form the hydrochloride. Methanol was distilled off to obtain 1-methyl-2-benzhydryl imino imidazolidine hydrochloride. Melting point: 254-256°C. Example
19 2-benzhydryl iminoimidazolidine 1.259
and sodium hydride 0.169 and ethyl iodide 1.
109, the reaction was carried out in the same manner as in Example 18,
1-Ethyl-2-benzhydryl iminoimidazolidine hydrochloride was obtained.
融点274〜276℃o実施例 20
2〒ベンズヒドリルイミノーイミダゾリジン2.519
と水素化ナトリウム(50%)0.609およびヨウ化
n−プロピル2.049を用い反応させ、以下実施例1
8と同様にして1−n−プロピル−2−ベンズヒドリル
イミノーイミダゾリジン塩酸塩を得た。Melting point 274-276°C o Example 20 2 Benzhydryl iminoimidazolidine 2.519
was reacted with sodium hydride (50%) 0.609 and n-propyl iodide 2.049, and the following Example 1
1-n-propyl-2-benzhydryliminoimidazolidine hydrochloride was obtained in the same manner as in 8.
融点261〜263℃。実施例 21
2−ベンズヒドリルイミノーイミダゾリジン2.519
と水素化ナトリウム0.349およびヨウ化−n−ブチ
ル2.589を用い反応させ、以下実施例18と同様に
して1−n−ブチル−2−ベンズヒドリルイミノーイミ
ダゾリジン塩酸塩を得た。Melting point: 261-263°C. Example 21 2-benzhydryl iminoimidazolidine 2.519
was reacted with 0.349 of sodium hydride and 2.589 of n-butyl iodide, and in the same manner as in Example 18, 1-n-butyl-2-benzhydryl iminoimidazolidine hydrochloride was obtained.
融点240〜242イC0実施例 22
2−ベンズヒドリルイミノ一1,3−ジアザシクロヘキ
サン2。Melting point 240-242C0 Example 22 2-benzhydryl imino-1,3-diazacyclohexane 2.
659と水素化ナトリウム0.349およびヨウ化メチ
ル2.09を用い反応させ、以下実施例18と同様にし
て1−メチル−2−ベンズヒドリルイミノ一1,3−ジ
アザシクロヘキサン塩酸塩を得た。659 using 0.349% of sodium hydride and 2.09% of methyl iodide to obtain 1-methyl-2-benzhydrylimino-1,3-diazacyclohexane hydrochloride in the same manner as in Example 18. Ta.
融点219〜221℃。実施例 23
2−ベンズヒドリルイミノ一1,3−ジアザシクロヘキ
サン2.659と水素化ナトリウム0.349およびヨ
ウ化エチル2.209を用い反応させ、以下実施例18
と同様にして1−エチル−2−ベンズヒドリルイミノ一
1,3−ジアザシクロヘキサン塩酸塩を得た。Melting point: 219-221°C. Example 23 2-benzhydrylimino-1,3-diazacyclohexane 2.659 was reacted with 0.349 sodium hydride and 2.209 ethyl iodide, and the following Example 18
In the same manner as above, 1-ethyl-2-benzhydrylimino-1,3-diazacyclohexane hydrochloride was obtained.
融点247〜249℃。実施例 242−(α−(p−
クロルフエニノ(ハ)ベンジノ(ハ)イミノ−イミダゾ
リジン1.409と水素化ナトリウム(50%)0.3
09およびヨウ化メチル0.809を用い反応させ、以
下実施例18と同様にして1−メチル−2−(α−(p
−クロロフエニル)ベンジル)イミノ−イミダゾリジン
硫酸塩を得た。Melting point 247-249°C. Example 242-(α-(p-
Chlorpheno(c)benzino(c)imino-imidazolidine 1.409 and sodium hydride (50%) 0.3
09 and methyl iodide, and the same procedure as in Example 18 was carried out to prepare 1-methyl-2-(α-(p
-chlorophenyl)benzyl)imino-imidazolidine sulfate was obtained.
融点206〜208イC0実施例 25
ベンズヒドリルイソシアニドジクロリドを乾燥エーテル
20m1に溶かし、メチルエチレンジアミン2f1を氷
冷下0〜5℃で加え室温で一夜攪拌した。Melting point 206-208 C0 Example 25 Benzhydryl isocyanide dichloride was dissolved in 20 ml of dry ether, methylethylenediamine 2f1 was added at 0-5° C. under ice cooling, and the mixture was stirred overnight at room temperature.
2規定一塩酸でPHlとしたのち析出する結晶を集め濾
取すると1−メチル−2−ベンズヒドリルイミノイミダ
ゾリジン塩酸塩を得た。After converting to PHL with 2N monohydrochloric acid, the precipitated crystals were collected and filtered to obtain 1-methyl-2-benzhydryl iminoimidazolidine hydrochloride.
融点254〜256℃。実施例 26
ベンズヒドリルイソシアニドジクロリドとエチレンジア
ミン4.29を乾燥エーテル40m1中以下実施例25
と同様に反応、処理して2−ベンズヒドリルイミノイミ
ダゾリジン塩酸塩を得た。Melting point: 254-256°C. Example 26 Benzhydryl isocyanide dichloride and 4.29 ml of ethylenediamine were mixed in 40 ml of dry ether as shown in Example 25.
The reaction and treatment were carried out in the same manner as above to obtain 2-benzhydryl iminoimidazolidine hydrochloride.
融点207〜209ルC0実施例 27
ベンズヒドリルイソシアニドジクロリドと1,3−ジア
ミノプロパンを実施例25と同様に反応処理して2−ベ
ンズヒドリルイミノ一1,3−ジアザシクロヘキサン塩
酸塩を得る。Melting point 207-209 C0 Example 27 Benzhydryl isocyanide dichloride and 1,3-diaminopropane are reacted in the same manner as in Example 25 to obtain 2-benzhydryl imino-1,3-diazacyclohexane hydrochloride. .
融点238〜242℃。実施例 28
ベンズヒドリルイソシアニドジクロリドと1,4−ジア
ミノブタンを以下実施例25と同様に反応、処理して2
−ベンズヒドリルイミノ一1,3−ジアザシクロヘプタ
ン塩酸塩を得る。Melting point 238-242°C. Example 28 Benzhydryl isocyanide dichloride and 1,4-diaminobutane were reacted and treated in the same manner as in Example 25 to obtain 2.
- Benzhydrylimino-1,3-diazacycloheptane hydrochloride is obtained.
融点227〜230℃。実施例 29
ベンズヒドリルイソシアニドジクロリドと1,2−ジア
ミノプロパンを以下実施例25と同様に反応、処理して
2−ベンズヒドリルイミノ一4メチル−イミダゾリジン
塩酸塩を得た。Melting point 227-230°C. Example 29 Benzhydryl isocyanide dichloride and 1,2-diaminopropane were reacted and treated in the same manner as in Example 25 to obtain 2-benzhydryl imino-14methyl-imidazolidine hydrochloride.
融点225〜227℃o実施例 30
N−ベンズヒドリル一S−メチルイソチウロニウムイオ
ダイド7.689とN−ヒドロキシエチルエチレンジア
ミン10.09をメタノール400m1中2時間加熱還
流し、冷後メタノールと過剰のアミンを減圧除去する。Melting point 225-227°C o Example 30 N-benzhydryl-S-methylisothiuronium iodide 7.689 and N-hydroxyethylethylenediamine 10.09 were heated to reflux in 400 ml of methanol for 2 hours, and after cooling, methanol and excess amine were mixed. is removed under reduced pressure.
残渣はメタノールに溶かし、10%苛性ソーダでアルカ
リ性としてクロロホルムで抽出し、水洗、乾燥後クロロ
ホルムを留去すると1−(2−ヒドロキシエチル)−2
−ベンズヒドリルイミノーイミダゾリジンが得られる。
融点132〜135℃o実施例 31
N−α−(2−ピリジル)ベンジル一S−メチルイソチ
ウロニウムイオダイド5.79とエチレンジアミン8.
59をメタノール40m1と共に以下実施例30と同様
に反応、処理して2−(α−(2−ピリジル)ベンジル
)イミノ−イミダゾリジンが得られる。The residue was dissolved in methanol, made alkaline with 10% caustic soda, extracted with chloroform, washed with water, dried, and the chloroform was distilled off to give 1-(2-hydroxyethyl)-2.
- A benzhydryl iminoimidazolidine is obtained.
Melting point 132-135°C o Example 31 N-α-(2-pyridyl)benzyl-S-methylisothiuronium iodide 5.79 and ethylenediamine 8.
59 with 40 ml of methanol and treated in the same manner as in Example 30 to obtain 2-(α-(2-pyridyl)benzyl)imino-imidazolidine.
融点199〜20rC0α−(0−クロロフエニル)ベ
ンジルイソシアニドジクロリドを、これとエチレンジア
ミン1.09を以下実施例25と同様に反応、処理して
2一(α−(0−クロロフエニル)ベンジル)イミノイ
ミダゾリジン塩酸塩を得た。Melting point 199-20rC0α-(0-chlorophenyl)benzyl isocyanide dichloride was reacted with ethylenediamine 1.09% in the same manner as in Example 25 to obtain 2-(α-(0-chlorophenyl)benzyl)iminoimidazolidine hydrochloride. Got salt.
融点205〜207℃o実施例 33
α−(p−クロロフエニノ(ハ)ベンジルイソシアニド
ジクロリドとエチレンジアミン1.09を実施例25と
同様に反応、処理して2−α−(p−クロロフエニル)
ベンジル)イミノイミダゾリジンを遊離塩基として得た
。Melting point 205-207°C o Example 33 α-(p-chlorophenino(ha)benzylisocyanide dichloride and 1.09 g of ethylenediamine were reacted and treated in the same manner as in Example 25 to produce 2-α-(p-chlorophenyl)
Benzyl)iminoimidazolidine was obtained as the free base.
融点187〜189℃o実施例 34α−(p−クロロ
フエニル)ベンジルイゾシアニドジクロリドとメチルエ
チレンジアミン1.19を実施例25と同様に反応、処
理して1−メチル−2−(α−(p−タロロフエニル)
ベンジル)イミノイミダゾリジンを硫酸塩として単離し
た。Example 34α-(p-chlorophenyl)benzylisocyanide dichloride and methylethylenediamine 1.19% were reacted and treated in the same manner as in Example 25 to obtain 1-methyl-2-(α-(p- (talolophenil)
The benzyl)iminoimidazolidine was isolated as the sulfate salt.
融点206〜208ンC0実施例 35
N−α−(p−メトキシフエニル)ベンジルS−メチル
イソチウロニウムイオダイド4.19とエチレンジアミ
ン3.01をメタノール30m1と共に実施例30と同
様に反応、処理して2−(α(p−メトキシフエニル)
ベンジノ(ハ)イミノイミダゾリジンを得た。Melting point 206-208 C0 Example 35 4.19 N-α-(p-methoxyphenyl)benzyl S-methylisothiuronium iodide and 3.01 ml of ethylenediamine were reacted and treated in the same manner as in Example 30 with 30 ml of methanol. and 2-(α(p-methoxyphenyl)
Benzino(c)iminoimidazolidine was obtained.
融点172〜174℃。実施例 36N−ジ一(p−ト
リノ(ハ)メチル−S−メチルイソチウロニウムイオダ
イド4,19とエチレンジアミン3.09をメタノール
307TL1と共に以下実施例30と同様に反応、処理
して2−ジ一(p−トリル)メチルイミノイミダゾリジ
ンを得た。Melting point: 172-174°C. Example 36N-di-(p-trino(ha)methyl-S-methylisothiuronium iodide 4,19 and ethylenediamine 3.09 were reacted and treated in the same manner as in Example 30 with methanol 307TL1 to obtain 2-di-1) Mono(p-tolyl)methyliminoimidazolidine was obtained.
融点195〜197℃。実施例 37
N−(α−シクロヘキシルベンジル)−S−メチルイソ
チウロニウムイオダイド3.9f1とエチレンジアミン
3.09をメタノール30m1と共に実施例30と同様
に反応し、処理して2−(α−シクロヘキシルベンジル
)イミノイミダゾリジンを得た。Melting point: 195-197°C. Example 37 3.9f1 of N-(α-cyclohexylbenzyl)-S-methylisothiuronium iodide and 3.09ml of ethylenediamine were reacted and treated in the same manner as in Example 30 with 30ml of methanol to give 2-(α-cyclohexylbenzyl). Benzyl)iminoimidazolidine was obtained.
融点203〜205℃。Melting point 203-205°C.
元素分析 Cl6H23N3として
計算値 C74.66,H9.Ol,Nl6.33分析
値 C74.48,H9.O3,Nl6.2l実施例
38
N−(α−( 2 −ピリジル)ベンジル)− S −
メチルイソチウロニウムイオダイド5.7f1とN−メ
チルエチレンジアミン101をメタノール40m1と共
に実施例30と同様に反応、処理して2一(α−( 2
−ピリジル)ベンジル)イミノイミダゾリジンを得た
。Elemental analysis Calculated value as Cl6H23N3 C74.66, H9. Ol, Nl6.33 analysis value C74.48, H9. O3, Nl 6.2l example
38 N-(α-(2-pyridyl)benzyl)-S-
5.7f1 of methylisothiuronium iodide and 101ml of N-methylethylenediamine were reacted and treated with 40ml of methanol in the same manner as in Example 30 to obtain 2-(α-(2
-pyridyl)benzyl)iminoimidazolidine was obtained.
融点127〜129℃o元素分析 Cl6Hl8N4と
して
計算値 C72.l5,H6.8l,N2l.O4分析
値 C72.42,H6.83,N2O.92実施例
39
N−ベンズヒドリル一 S −メチルイソチウロニウム
イオダイド1.72f1とN−イソプロピルエチレンジ
アミン1.9Iを混和し、5時間加熱反応し、実施例3
0と同様に処理して1−イソプロピル−2−ベンズヒド
リノレイミノーイミダゾリジン・ヨウ化水素酸塩を得た
。Melting point 127-129°C o Elemental analysis Calculated value as Cl6Hl8N4 C72. l5, H6.8l, N2l. O4 analysis value C72.42, H6.83, N2O. 92 examples
39 1.72 f1 of N-benzhydryl-S-methylisothiuronium iodide and 1.9 I of N-isopropylethylenediamine were mixed and reacted by heating for 5 hours. Example 3
1-isopropyl-2-benzhydrinoleiminoimidazolidine hydroiodide was obtained in the same manner as in Example 0.
融点200〜202℃o元素分析 C,,H24N,I
としてMelting point 200-202℃o Elemental analysis C,,H24N,I
as
Claims (1)
シクロアルカン類化合物又はその塩▲数式、化学式、表
等があります▼ 式中R_1は水素、ハロゲン又は低級アルキルを、R_
2はシクロアルキル、ピリジル又はハロゲン、低級アル
キル若しくは低級アルコキシが置換することあるフェニ
ルを、R_3は水素、低級アルキル、ヒドロキシアルキ
ル又はアラルキルを、R_4は水素、低級アルキル又は
フェニルを、nは1〜3を意味する。 2 特許請求の範囲1の化合物において、R_1が水素
、R_2がフェニル、R_3が水素又は低級アルキル、
R_4が水素、nが1である特許請求の範囲第1項の化
合物又はその塩。 3 1−メチル−2−ベンズヒドリルイミノイミダゾリ
ジン又はその塩である特許請求の範囲第1項の化合物。 4 次の一般式で表わされる2−置換−1,3−ジアザ
シクロアルカン類化合物又はその塩を有効成分とする血
糖降下剤。 ▲数式、化学式、表等があります▼ 但し、R_1は水素、ハロゲン又は低級アルキルを、R
_2は低級アルキル、シクロアルキル、ピリジル又はハ
ロゲン、低級アルキル若しくは低級アルコキシが置換す
ることあるフェニルを、R_3は水素、低級アルキル、
ヒドロキシアルキル又はアラルキルを、R_4は水素、
低級アルキル又はフェニルを、nは1〜3を意味する。 5 有効成分が1−メチル−2−ベンズヒドリルイミノ
イミダゾリジン又はその塩である特許請求の範囲第4項
の血糖降下剤。[Claims] 1. A 2-substituted-1,3-diazacycloalkane compound or a salt thereof represented by the following general formula ▲ Numerical formulas, chemical formulas, tables, etc. are available ▼ In the formula, R_1 is hydrogen, halogen, or lower Alkyl, R_
2 is phenyl which may be substituted with cycloalkyl, pyridyl or halogen, lower alkyl or lower alkoxy, R_3 is hydrogen, lower alkyl, hydroxyalkyl or aralkyl, R_4 is hydrogen, lower alkyl or phenyl, n is 1-3 means. 2 In the compound of claim 1, R_1 is hydrogen, R_2 is phenyl, R_3 is hydrogen or lower alkyl,
The compound or salt thereof according to claim 1, wherein R_4 is hydrogen and n is 1. 3. The compound according to claim 1, which is 1-methyl-2-benzhydryl iminoimidazolidine or a salt thereof. 4. A hypoglycemic agent containing a 2-substituted-1,3-diazacycloalkane compound represented by the following general formula or a salt thereof as an active ingredient. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ However, R_1 is hydrogen, halogen, or lower alkyl, and R
_2 is lower alkyl, cycloalkyl, pyridyl, or phenyl which may be substituted with halogen, lower alkyl or lower alkoxy; R_3 is hydrogen, lower alkyl,
hydroxyalkyl or aralkyl, R_4 is hydrogen,
lower alkyl or phenyl; n means 1-3; 5. The hypoglycemic agent according to claim 4, wherein the active ingredient is 1-methyl-2-benzhydryl iminoimidazolidine or a salt thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20276A JPS5938227B2 (en) | 1976-01-01 | 1976-01-01 | 2-substituted-1,3-diazacycloalkane compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20276A JPS5938227B2 (en) | 1976-01-01 | 1976-01-01 | 2-substituted-1,3-diazacycloalkane compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5283559A JPS5283559A (en) | 1977-07-12 |
| JPS5938227B2 true JPS5938227B2 (en) | 1984-09-14 |
Family
ID=11467385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP20276A Expired JPS5938227B2 (en) | 1976-01-01 | 1976-01-01 | 2-substituted-1,3-diazacycloalkane compounds |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5938227B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101687812A (en) * | 2007-07-02 | 2010-03-31 | 弗·哈夫曼-拉罗切有限公司 | 2-Imidazoline Compounds with Good Affinity for Trace Amine-Associated Receptors (TAARs) |
-
1976
- 1976-01-01 JP JP20276A patent/JPS5938227B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5283559A (en) | 1977-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU450398A3 (en) | The method of obtaining -aryl-2-aminoalkoxystyrene | |
| FI75821C (en) | Process for the preparation of therapeutically active 2-guanidino-4-hot roarylthiazoles | |
| EP0101574B1 (en) | 2-substituted 1-aminoalkyl-1,2,3,4-tetrahydro-beta-carbolines, their preparation and use as medicaments | |
| Archibald et al. | Synthesis and hypotensive activity of benzamidopiperidylethylindoles | |
| JPS62252780A (en) | Novel indenothiazole derivative and production thereof | |
| SU812175A3 (en) | Method of preparing substituted 2-pnenyliminoimidazolidines or their salts | |
| JPS63310872A (en) | Dopamine-beta-hydroxylase inhibitor | |
| US5120736A (en) | 4-methyl-5-(2-(4-phenylpiperazin-1-yl)ethyl)thiazole derivatives their method of preparation and the pharmaceutical compositions in which they are present | |
| JPS5938227B2 (en) | 2-substituted-1,3-diazacycloalkane compounds | |
| Santilli et al. | 8, 9, 10, 11-Tetrahydro-12H-benzo [5, 6] quinoxalino-[2, 3-e][1, 4] diazepin-12-ones. Examples of a New Heterocyclic Ring System | |
| US3629266A (en) | (phenyl piperidino alkyl)3 4-dihydrocarbostyrils | |
| US4208420A (en) | New benzo [d] thiazole derivatives, process for their preparation and their therapeutic applications | |
| US3530140A (en) | Certain pyridyl-hydrazino-2-yl-imidazolines | |
| US4808727A (en) | Imidazolium hydrogen carbonates | |
| JPS5841863A (en) | Isoindolin-2-yl-amino-imidazoline and isoindolin-2-yl-guanidine and manufacture | |
| US4073905A (en) | 2-Amino-4-phenyl-2-imidazolines and salts thereof | |
| US2991289A (en) | Derivatives of 1-aminopropane | |
| EP0000151B1 (en) | 1-substituted aminoindolines, process for their production and pharmaceutical compositions containing them | |
| JPS6157307B2 (en) | ||
| US4206217A (en) | 3-[4-(1,3-Diazacycloalken-2-yl)-phenyl]-1,2-benzisothiazoles, their manufacture, and drugs containing these compounds | |
| US3592852A (en) | Substituted benzylideneamino guanidine | |
| US3189599A (en) | 1-[2-(n, n-alkylene-imino)-alkyl]-3-aminoguanidines and intermediates therefor | |
| GB2068963A (en) | Basic ethers of 4-hydroxy-benzophenones acting as beta-blocking agents and relevant preparation processes | |
| JPS6410512B2 (en) | ||
| JPS6354371A (en) | Substituted benzimidazolylthiomethylbenzothiazole and salt, manufacture and use as drug |